GLF
RPRX icon

Groupe la Francaise’s Royalty Pharma RPRX Stock Holding History

Groupe la Francaise’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Buy
216
+22
+11% +$1.15K ﹤0.01% 460
2026
Q1 		$9.31K Buy
+194
New +$8.5K ﹤0.01% 431

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Groupe la Francaise's RPRX Position: Q2 2026 in Review

Groupe la Francaise increased its Royalty Pharma (RPRX) stake by 11% in Q2 2026, buying an estimated $1.15K and bringing the position to 216 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #460.

Groupe la Francaise first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Groupe la Francaise held 216 shares of Royalty Pharma worth $12.1K as of Q2 2026.
  • Groupe la Francaise bought 22 Royalty Pharma shares in Q2 2026, an estimated $1.15K.
  • Royalty Pharma made up ﹤0.01% of Groupe la Francaise's portfolio in Q2 2026, its #460 holding.
  • Groupe la Francaise first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.